
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 28 October 2020
Sec. Mucosal Immunity
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.592865
This article is a correction to:
Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
Corrigendum on
Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
by Ryffel, B., Huang, F., Robinet, P., Panek, C., Couillin, I., Erard, F., et al. (2019). Front. Immunol. 10:702. doi: 10.3389/fimmu.2019.00702
In the published article, there was an error in affiliation 2. Instead of “UMR 7355 Université-CNRS INEM, Orléans, France and IDM, University of Cape Town, South Africa”, it should be “INEM UMR 7355 CNRS and University of Orleans, Orléans, France.”
In addition, the wrong microscopic plates were inserted into Figures 5E and F. The corrected Figure 5 appears below.
Figure 5. IL-22 confers protection in IL-33R/ST2 deficient mice upon T. gondii infection Infection by T. gondii infection induces enhanced IL22 mRNA and protein expression in ST2 deficient mice (A,B) and increased IL-33 expression (B). Administration of rmIL-22 reduces MPO activity, CXCL1/KC levels, neutrophil recruitment (C) and severity of ileitis in B6 mice (D). By contrast, IL-22 antibody blockade in IL-33R/ST2 deficient mice increased MPO activity, CXCL1/KC levels and neutrophil recruitment (E) and enhanced severity of ileitis (F). Analysis at day 7 post-infection. Values are representative of two independent experiments.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Toxoplasma gondii, IL-33/ST2 receptor, neutralizing antibody, IL-22, parasite-induced ileitis, innate immunity
Citation: Ryffel B, Huang F, Robinet P, Panek C, Couillin I, Erard F, Piotet J, Le Bert M, Mackowiak C, Torres Arias M, Dimier-Poisson I and Zheng SG (2020) Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression. Front. Immunol. 11:592865. doi: 10.3389/fimmu.2020.592865
Received: 08 August 2020; Accepted: 25 August 2020;
Published: 28 October 2020.
Edited and reviewed by: Fang-Ping Huang, Shenzhen University, China
Copyright © 2020 Ryffel, Huang, Robinet, Panek, Couillin, Erard, Piotet, Le Bert, Mackowiak, Torres Arias, Dimier-Poisson and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bernhard Ryffel, YmVybmhhcmQucnlmZmVsQGNucnMtb3JsZWFucy5mcg==; Song Guo Zheng, U29uZ0d1by5aaGVuZ0Bvc3VtYy5lZHU=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.